{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:13:18Z","timestamp":1777320798288,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.trim.2023.101885","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T03:53:10Z","timestamp":1688442790000},"page":"101885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Role of standard HLA mismatch in modifying associations between non-pharmacologic risk factors and solid organ malignancy after kidney transplantation"],"prefix":"10.1016","volume":"80","author":[{"suffix":"Jr","given":"Alfonso H.","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhannad A.","family":"Leghrouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawther","family":"Alquadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Belal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuerong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2023.101885_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34971","article-title":"Survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across ages in transplant-eligible patients with kidney failure","author":"Strohmaier","year":"2022","journal-title":"JAMA New Open"},{"issue":"1","key":"10.1016\/j.trim.2023.101885_bb0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.transproceed.2015.10.058","article-title":"Quality of life after kidney transplantation: a prospective study","volume":"48","author":"Kostro","year":"2016","journal-title":"Transplant. Proc."},{"issue":"7","key":"10.1016\/j.trim.2023.101885_bb0015","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/TP.0000000000002961","article-title":"Late graft loss after kidney transplantation: is \u201cdeath with function\u201d really death with a functioning allograft?","volume":"104","author":"Gaston","year":"2020","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101885_bb0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41581-018-0022-6","article-title":"Cancer in kidney transplant recipients","volume":"14","author":"Au","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.trim.2023.101885_bb0025","doi-asserted-by":"crossref","first-page":"1848068","DOI":"10.1080\/2162402X.2020.1848068","article-title":"Cancer risks in solid organ transplant recipients: results from a comprehensive analysis of 72 cohort studies","volume":"9","author":"Huo","year":"2020","journal-title":"Oncoimmunology."},{"issue":"4","key":"10.1016\/j.trim.2023.101885_bb0030","first-page":"16","article-title":"Associations of human leukocyte antigen (HLA) haplotypes with risk of developing lymphoproliferative disorders after renal transplantation","volume":"12","author":"Pourfarziani","year":"2007","journal-title":"Ann. Transpl. Oct-Dec"},{"key":"10.1016\/j.trim.2023.101885_bb0035","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1097\/TP.0000000000001025","article-title":"HLA and risk of diffuse large B cell lymphoma after solid organ transplantation","volume":"100","author":"Hussain","year":"2016","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.trim.2023.101885_bb0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamadermatol.2018.4983","article-title":"Association of HLA antigen mismatch with risk of developing skin cancer after solid-organ transplant","volume":"155","author":"Gao","year":"2019","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.trim.2023.101885_bb0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.tp.0000173793.03228.bd","article-title":"HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical","volume":"80","author":"Bakker","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2023.101885_bb0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.humimm.2017.02.002","article-title":"Cutaneous squamous cell cancer (cscC) risk and the human leukocyte antigen (HLA) system","volume":"78","author":"Yesantharao","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2023.101885_bb0055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/1523-1747.ep12292086","article-title":"Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia","volume":"108","author":"Bouwes Bavinck","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.trim.2023.101885_bb0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJM199109193251203","article-title":"Relation between skin cancer and HLA antigens in renal-transplant recipients","volume":"325","author":"Bouwes Bavinck","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.trim.2023.101885_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0714.2011.01072.x","article-title":"The prevalence of dysplasia and malignant lip lesions in transplant patients","volume":"41","author":"Nolan","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.trim.2023.101885_bb0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101885_bb0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/TP.0b013e3181c69855","article-title":"Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation","volume":"89","author":"Opelz","year":"2010","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.trim.2023.101885_bb0080","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1111\/j.1600-6143.2012.04226.x","article-title":"Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report","volume":"12","author":"Opelz","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2023.101885_bb0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00007890-200407271-01349","article-title":"Influence of HLA mismatch and recipient HLA status on tumor development after renal transplantation","volume":"78","author":"Wimmer","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2023.101885_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12631","article-title":"Cytomegalovirus, and cancer after kidney transplantation: role of the human leukocyte antigen system?","volume":"19","author":"Wong","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101885_bb0095","doi-asserted-by":"crossref","first-page":"101391","DOI":"10.1016\/j.trim.2021.101391","article-title":"Association of HLA mismatch and MTOR inhibitor regimens with malignancy and mortality after kidney transplantation","volume":"66","author":"Santos","year":"2021","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2023.101885_bb0100","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12889-023-15600-3","article-title":"Associations of free sugars from solid and liquid sources with cardiovascular disease: a retrospective cohort analysis","volume":"3","author":"Dasgupta","year":"2023","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.trim.2023.101885_bb0105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2215\/CJN.10301016","article-title":"Chronic renal insufficiency cohort (CRIC) study investigators. Statistical methods for cohort studies of CKD: survival analysis in the setting of competing risks","volume":"12","author":"Hsu","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"7382","key":"10.1016\/j.trim.2023.101885_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.trim.2023.101885_bb0115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12889-022-12849-y","article-title":"Comparison of mortality hazard ratios associated with health behaviours in Canada and the United States: a population-based linked health survey study","volume":"22","author":"Fisher","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.trim.2023.101885_bb0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fimmu.2016.00575","article-title":"HLA mismatching strategies for solid organ transplantation - a balancing act","volume":"7","author":"Zachary","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2023.101885_bb0125","doi-asserted-by":"crossref","first-page":"E428","DOI":"10.1111\/j.1399-0012.2012.01654.x","article-title":"Human leukocyte mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients","volume":"26","author":"Lim","year":"2012","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101885_bb0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12882-018-0908-3","article-title":"What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients","volume":"19","author":"Shi","year":"2018","journal-title":"BMC Nephrol."},{"issue":"9","key":"10.1016\/j.trim.2023.101885_bb0135","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1600-6143.2007.01908.x","article-title":"Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients","volume":"7","author":"Webster","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101885_bb0140","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0000000000000375","article-title":"The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis","volume":"98","author":"Ma","year":"2014","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2023.101885_bb0145","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.mayocp.2018.04.025","article-title":"Immunosuppression, race, and donor-related risk factors affect de novo cancer incidence across solid organ transplant recipients","volume":"93","author":"Bhat","year":"2018","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.trim.2023.101885_bb0150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ajt.12066","article-title":"Racial\/ethnic differences in cancer risk after kidney transplantation","volume":"13","author":"Hall","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2023.101885_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158732","article-title":"Independent pre-transplant recipient cancer risk factors after kidney transplantation and the utility of g-chart analysis for clinical process control","volume":"11","author":"Schrem","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.trim.2023.101885_bb0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015677","article-title":"Cancer in the transplant recipient","volume":"3","author":"Chapman","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.trim.2023.101885_bb0165","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1681\/ASN.2013101122","article-title":"Polycystic kidney disease and cancer after renal transplantation","volume":"25","author":"Wetmore","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.trim.2023.101885_bb0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/TP.0b013e31827743b4","article-title":"Time on dialysis and cancer risk after kidney transplantation","volume":"95","author":"Wong","year":"2013","journal-title":"Transplantation."},{"issue":"6","key":"10.1016\/j.trim.2023.101885_bb0175","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1062860611403135","article-title":"The implications of using adjusted versus unadjusted methods to measure health care disparities at the practice level","volume":"26","author":"Jean-Jacques","year":"2011","journal-title":"Am. J. Med. Qual."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:03:49Z","timestamp":1760810629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":35,"alternative-id":["S0966327423001028"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101885","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of standard HLA mismatch in modifying associations between non-pharmacologic risk factors and solid organ malignancy after kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101885"}}